Outcomes of MIST for BPH: A Single-Institution Prospective Study
The investigators wish to perform a prospective study at the Men's Health Clinic in Winnipeg, Manitoba to accomplish two goals: 1) Prospectively describe 1 year outcomes for MIST therapies performed at the clinic 2) perform a head to head comparison of Rezum water vapor therapy vs the iTind device in respect to symptom score improvement, uroflow parameters and side effect profile.
- EligibilityCriteria: Inclusion Criteria:  patients > 18 years of age undergoing Rezum or iTind treatment  Exclusion Criteria:  ASA 3 or higher, active UTI within past week, age < 18 years of age, no informed consent - HealthyVolunteers: Accepts Healthy Volunteers - Gender: Male - MinimumAge: 18 Years - MaximumAge: 65 Years - StdAgeList: Adult, Older Adult